A pilot trial of complement inhibition using eculizumab to overcome platelet transfusion refractoriness in human leukocyte antigen alloâimmunized patients
Vo, Phuong, Purev, Enkhtsetseg, West, Kamille A., McDuffee, Emily, Worthy, Tatyana, Cook, Lisa, Hawks, Geri, Wells, Brian, Shalabi, Reem, Flegel, Willy A., Adams, Sharon D., Reger, Robert, Aue, Georg,Language:
english
Journal:
British Journal of Haematology
DOI:
10.1111/bjh.16385
Date:
February, 2020
File:
PDF, 274 KB
english, 2020